Dendritic cell vaccine for relapsed neuroblastoma patient induces complete remission

(Solving Kids' Cancer) One year after his last treatment, a six-year-old boy with recurrent neuroblastoma is in complete remission for his high-risk metastatic cancer. Doctors reported this case study in the Jan. 2013 issue of Pediatrics, the journal of the American Academy of Pediatrics.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news